Full Press Release Details
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s Well Summit, taking place from September 28 to 30, 2026, in New York. Mr. Fried is scheduled to participate in the Aging on Trial: Peptides, Hormones, and the Line Between Brea